Trial
NCT02995083
Intra-articular Injections for Knee Osteoarthritis: A Single Blinded Prospective Randomized Trial
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
—
Condition
Symptomatic Osteoarthritis of the Knee
Intervention
40 mg Depo-Medrol in 1 ml, 9 ml of 1% lidocaine
Why stopped
Study deemed not feasible
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-18